23145-65-5 Usage
Description
4-(Bromomethyl)-2-methoxy-1-nitrobenzene is an organic compound with the molecular formula C7H6BrNO3. It is a synthetic chemical used as an intermediate in the production of various compounds, particularly in the pharmaceutical and chemical industries. 4-(BROMOMETHYL)-2-METHOXY-1-NITROBENZENE features a bromine atom attached to a benzene ring, a methoxy group, and a nitro group, which contribute to its reactivity and utility in chemical synthesis.
Uses
Used in Pharmaceutical Industry:
4-(Bromomethyl)-2-methoxy-1-nitrobenzene is used as a synthetic intermediate for the production of 4-Amino-m-tyrosine (A632020), a compound that is a degradation product of Pheomelanin. Pheomelanin is a pigment found in human hair and skin, and its degradation products have been studied for their potential roles in various biological processes and diseases.
Used in Chemical Synthesis:
In the chemical industry, 4-(Bromomethyl)-2-methoxy-1-nitrobenzene serves as a versatile building block for the synthesis of a range of other organic compounds. Its unique functional groups, including the bromine atom, methoxy group, and nitro group, make it a valuable precursor for the development of new molecules with potential applications in various fields, such as materials science, pharmaceuticals, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 23145-65-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,1,4 and 5 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23145-65:
(7*2)+(6*3)+(5*1)+(4*4)+(3*5)+(2*6)+(1*5)=85
85 % 10 = 5
So 23145-65-5 is a valid CAS Registry Number.
23145-65-5Relevant articles and documents
SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF
-
Page/Page column 144, (2021/07/02)
The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.
COMPOUNDS FOR TREATMENT OF CARDIAC ARRHYTHMIAS AND HEART FAILURE
-
Page/Page column 53, (2019/10/19)
This disclosure concerns compounds and a method for modulating the activity of calcium ion channels, including Ca2+-induced (or Ca2+-activated) calcium release channels and conformationally coupled calcium release channels such as ryanodine receptors. Some of the compounds have a structure according to formula I, or a stereoisomer, tautomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof.
PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS
-
Paragraph 0713, (2014/02/15)
The present invention relates to the use of certain pyrrolopyridineamino derivatives (hereinafter referred to as “PPA derivatives”), particularly 1H-pyrrolo[3,2-c]pyridine-6-amino derivatives, to inhibit the spindle checkpoint function of Monospindle 1 (Mps1—also known as TTK) kinases either directly or indirectly via interaction with the Mps kinase itself. In particular, the present invention relates to PPA derivatives for use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of the PPA derivatives, and pharmaceutical compositions comprising them. Formula (I)
